Shrewsbury Town chief executive Liam Dooley says the League Two club have cut their financial losses by more than half.
A homegrown biopharma developing cell therapies for cancers and other diseases is set to be acquired by Gilead Sciences — for ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する